Patterns of Neurodevelopmental Disorders

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Richard Frye
Study ID
NCT06213090
Status
Recruiting
Apply to this trial

Conditions

  • Autism Spectrum Disorder
  • Cerebral Folate Deficiency
  • Down Syndrome
  • Epilepsy
  • Mitochondrial Encephalomyopathies
  • Neurodevelopmental Disorders
  • Pediatric Acute-Onset Neuropsychiatric Syndrome
  • Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infection

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.

Key Dates

Start date
Feb 1, 2024
Status verified
Apr 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Autism
    Children with autism will be followed in regards to their clinical management.
  • Arm: Mitochondrial Encephalopathy
    Children with Mitochondrial Encephalopathy will be followed in regards to their clinical management.
  • Arm: Down Syndrome
    Children with Down Syndrome will be followed in regards to their clinical management.
  • Arm: Cerebral Folate Deficiency
    Children with Cerebral Folate Deficiency will be followed in regards to their clinical management.
  • Arm: PANS
    Children with PANS will be followed in regards to their clinical management.
  • Arm: PANDAS
    Children with PANDAS will be followed in regards to their clinical management.
  • Arm: Epilepsy
    Children with Epilepsy will be followed in regards to their clinical management.
  • Arm: ADHD
    Children with ADHD will be followed in regards to their clinical management.
  • Arm: Dyslexia and other learning disabilities
    Children with Dyslexia and other learning disabilities will be followed in regards to their clinical management.
  • Arm: Other Neurodevelopmental Disorders
    Children with Other Neurodevelopmental Disorders will be followed in regards to their clinical management.

Primary Outcome Measure

Number of Patients with Specific Medical abnormalities [ Time Frame: up to 7 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Rossignol Medical CenterPhoenixArizona85050
Richard E Frye, MD, PhD
[email protected]
281-546-8377

Find similar trials in Phoenix, AZ

By condition
Autism spectrum disorderEpilepsy
By specialty
PediatricsNeurologyBrain disorders
By research site
Rossignol Medical Center· Phoenix, AZ

Related Studies